Related Experiment Video
Updated: Feb 28, 2026
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Structural and functional analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in
A Iolascon1, L Giordani, A Moretti
1Department of Biomedicina dell'Età Evolutiva, Università di Bari, Italy.
Abstract:
The status of the CDKN2A gene family, including CDKN2A, CDKN2B, and CDKN2C, was investigated in 24 cases of neuroblastoma. These genes were selected on the basis of 1) high incidence of their inactivation in several human cancers and 2) their localization on chromosomal regions (9p and 1p) frequently rearranged in neuroblastomas. Detailed molecular analyses indicated the absence of homozygous deletions and point mutations involving these genes in all investigated tumor samples. However, when loss of heterozygostity for chromosome 9p21 (the region where CDKN2A and CDKN2B are localized) was investigated, 16% of cases showed abnormalities in an area telomeric to the CDKN2A locus. To study transcriptional silencing of the CDKN2A gene, the methylation status of exon 1 was examined. In about 35% of cases, a partial methylation was evidenced. Analysis of the CDKN2A mRNA expression, however, did not show any relationship between methylation status and gene transcription. Finally, expression of the CDKN2B gene was demonstrated in all stage IV neuroblastomas, whereas none of stage I tumors expressed this gene. This finding suggests the occurrence of a correlation between CDKN2B transcription and tumor phenotype.
Insights
Investigating the CDKN2A gene family in neuroblastoma revealed no mutations but identified chromosomal abnormalities and partial methylation of CDKN2A. CDKN2B expression correlated with advanced tumor stage.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The CDKN2A gene family (CDKN2A, CDKN2B, CDKN2C) is frequently inactivated in human cancers.
- These genes are located on chromosomal regions 9p and 1p, often rearranged in neuroblastoma.
- Understanding their status in neuroblastoma is crucial for cancer research.
Purpose of the Study:
- To investigate the molecular status of the CDKN2A gene family in neuroblastoma.
- To determine the frequency of genetic alterations and epigenetic modifications.
- To explore the correlation between gene expression and tumor phenotype.
Main Methods:
- Analysis of homozygous deletions and point mutations in CDKN2A, CDKN2B, and CDKN2C.
- Assessment of loss of heterozygosity on chromosome 9p21.
- Examination of CDKN2A promoter methylation status and mRNA expression.
- Evaluation of CDKN2B gene expression in different tumor stages.
Main Results:
- No homozygous deletions or point mutations were found in the studied genes.
- 16% of neuroblastoma cases showed chromosomal abnormalities telomeric to CDKN2A.
- Approximately 35% of cases exhibited partial methylation of CDKN2A exon 1, but this did not correlate with transcription.
- CDKN2B was expressed in all stage IV neuroblastomas but not in stage I tumors.
Conclusions:
- Genetic alterations like deletions and mutations are not the primary mechanism for CDKN2A family inactivation in neuroblastoma.
- Epigenetic modifications (methylation) and chromosomal rearrangements may play a role.
- CDKN2B expression is significantly associated with advanced neuroblastoma stages, suggesting its involvement in tumor progression.
More Related Videos
12:26Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
02:34Inhibition of Cdk Activity
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:15M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:39Positive Regulator Molecules
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:23Negative Regulator Molecules